<DOC>
	<DOCNO>NCT02322762</DOCNO>
	<brief_summary>DISCOVER Non Interventional Study study describe disease management pattern clinical evolution three year type 2 diabetes mellitus patient initiate second line anti-diabetic treatment .</brief_summary>
	<brief_title>DISCOVERing Treatment Reality Type 2 Diabetes Real World Settings</brief_title>
	<detailed_description>DISCOVER NIS study describe disease management pattern clinical evolution three year type 2 diabetes mellitus patient initiate second line anti-diabetic treatment . This study multi-country , multicenter , observational , prospective , longitudinal cohort study . The patient recruitted country Latin America , Europe Asia pac . It estimate approximately 13350 patient enrolled total patient follow 3 year .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>1 . Provision subject inform consent 2 . Female male age 18 year 3 . Diagnosed type 2 diabetes mellitus 4 . Initiating second line antidiabetic therapy , either addon , switch one monotherapy another . 1 . Diagnosis type 1 diabetes mellitus 2 . Patient pregnant 3 . Patients initiate dual therapy previously receive two different line monotherapy ( e.g . : Metformin → SU ( Sulphonylureas ) → SU+Addon ) 4 . Current treatment chemotherapy , oral iv steroid 5 . Patient dialysis renal transplant 6 . The patient take insulin first line treatment 7 . The patient take dual therapy fix dose combination treatment first line treatment . 8 . The patient take herbal remedy / natural medicine first line treatment 9 . Participation interventional trial 10 . Presence condition/circumstance opinion investigator could significantly limit complete follow patient 3 year ( e.g . lifethreatening comorbidities , tourist , nonnative speaker understand local language interpreter service reliably available , psychiatric disturbance , dementia , alcohol drug abuse ) . 11 . Not willing sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Anti-diabetic management pattern</keyword>
</DOC>